1. Home
  2. INDP vs GV Comparison

INDP vs GV Comparison

Compare INDP & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • GV
  • Stock Information
  • Founded
  • INDP 2000
  • GV 2013
  • Country
  • INDP United States
  • GV Canada
  • Employees
  • INDP N/A
  • GV N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • INDP Health Care
  • GV Real Estate
  • Exchange
  • INDP Nasdaq
  • GV Nasdaq
  • Market Cap
  • INDP 6.0M
  • GV 6.8M
  • IPO Year
  • INDP N/A
  • GV 2022
  • Fundamental
  • Price
  • INDP $3.87
  • GV $1.63
  • Analyst Decision
  • INDP Strong Buy
  • GV
  • Analyst Count
  • INDP 2
  • GV 0
  • Target Price
  • INDP $238.00
  • GV N/A
  • AVG Volume (30 Days)
  • INDP 1.4M
  • GV 772.5K
  • Earning Date
  • INDP 11-11-2025
  • GV 10-31-2025
  • Dividend Yield
  • INDP N/A
  • GV N/A
  • EPS Growth
  • INDP N/A
  • GV N/A
  • EPS
  • INDP N/A
  • GV N/A
  • Revenue
  • INDP N/A
  • GV $7,773,905.00
  • Revenue This Year
  • INDP N/A
  • GV N/A
  • Revenue Next Year
  • INDP N/A
  • GV N/A
  • P/E Ratio
  • INDP N/A
  • GV N/A
  • Revenue Growth
  • INDP N/A
  • GV N/A
  • 52 Week Low
  • INDP $2.22
  • GV $1.00
  • 52 Week High
  • INDP $58.24
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • INDP 50.07
  • GV 42.86
  • Support Level
  • INDP $3.35
  • GV $1.45
  • Resistance Level
  • INDP $4.00
  • GV $1.81
  • Average True Range (ATR)
  • INDP 0.77
  • GV 0.18
  • MACD
  • INDP 0.12
  • GV -0.05
  • Stochastic Oscillator
  • INDP 42.15
  • GV 24.66

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: